Lyra Therapeutics (LYRA)
NASDAQ:LYRA
US Market
Holding LYRA?
Track your performance easily

Lyra Therapeutics (LYRA) Financial Statements

250 Followers

Lyra Therapeutics Financial Overview

Lyra Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.625; its P/E ratio is -0.17; Lyra Therapeutics is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 598.00K$ 532.00K$ 146.00K$ 544.00K$ 458.00K
Gross Profit$ 598.00K$ 532.00K$ 146.00K$ 544.00K$ 458.00K
EBIT$ -48.12M$ -22.44M$ -15.19M$ -15.63M$ -15.61M
EBITDA$ -47.04M$ -23.23M$ -15.19M-$ -16.25M
Net Income Common Stockholders$ -48.13M$ -22.45M$ -15.18M$ -15.65M$ -15.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 67.50M$ 87.10M$ 102.75M$ 102.55M$ 116.45M
Total Assets$ 94.58M$ 141.53M$ 142.60M$ 120.58M$ 125.67M
Total Debt$ 36.75M$ 37.86M$ 26.88M$ 6.29M$ 1.69M
Net Debt$ -30.76M$ -49.24M$ -75.87M$ -96.26M$ -114.77M
Total Liabilities$ 63.60M$ 64.02M$ 53.18M$ 36.34M$ 27.10M
Stockholders Equity$ 30.98M$ 77.50M$ 89.42M$ 84.24M$ 98.63M
Cash Flow-
Free Cash Flow$ -20.18M$ -24.60M$ -19.84M-$ -14.35M
Operating Cash Flow$ -19.98M$ -22.45M$ -19.06M$ -14.11M$ -14.28M
Investing Cash Flow$ 36.18M$ 7.86M$ -2.36M$ -14.98M$ -561.00K
Financing Cash Flow$ -89.00K$ 8.64M$ 18.92M$ -418.00K$ 47.19M
Currency in USD

Lyra Therapeutics Earnings and Revenue History

Lyra Therapeutics Debt to Assets

Lyra Therapeutics Cash Flow

Lyra Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis